Instructions for Authorscdn.elsevier.com/promis_misc/janacauthorinfostyle... · The Journal of the...

Journal of the Association of Nurses in AIDS Care, Instructions for Authors, August 24, 2013 p. 1

Instructions for Authors

The Journal of the Association of Nurses in AIDS Care (JANAC) is the official journal of the Association of Nurses in AIDS Care (ANAC). JANAC’s mission is to support nursing practice, research, and education through the dissemination of scholarly, cutting-edge knowledge and practice standards. JANAC provides a forum for the interdisciplinary discussion of clinical practice, education, research, prevention, public health, health administration, international health, legal-ethical issues, social issues, and public policy related to all aspects of the HIV epidemic. JANAC invites original articles from nurses and other health care professionals that focus on a broad spectrum of issues related to HIV, nursing, public health, and clinical care.

Publishing with JANAC

JANAC offers a variety of publication options, including traditional print with online ahead of print, online only, and open access. Manuscripts must go through peer review and editing processes prior to being accepted for any form of publication.

Print with Online Ahead of Print

Authors may opt for traditional print publication. After a paper is accepted for publication, type set, and given final author approval, it will be placed into the publication queue. Print publication will usually take place within 12 months of acceptance. All articles accepted for publication will be published online ahead of print in a fully citable, but not final, format, until they are published in a print issue. The final format will include volume, issue, and page numbers.

Online Only Publication

JANAC offers the opportunity to publish accepted articles online only. These articles will not appear in JANAC’s printed pages. Instead, online-only articles are listed in the table of contents of the next available print issue and readers are directed to a URL to retrieve the articles in a final, fully citable format with e-page numbers. Online-only publication allows authors to publish their work in a more timely manner than waiting for print publication.

Open Access Publication

Open Access provides peer-reviewed scholarly research to readers via the Internet. Open Access articles are freely available to both subscribers and the wider public with permitted reuse based on individual copyright agreements.

Funding body agreements. You may access information about Elsevier’s agreement with specific funding bodies here: http://www.elsevier.com/journal-authors/funding-body-agreements

JANAC follows the policy and procedure of its publisher, Elsevier, to comply with the NIH Access Mandate. All reports of NIH-funded research accepted for publication in JANAC will be handled in the following manner.

Elsevier will send to PMC [PubMed Central] the final peer-reviewed manuscript, which was accepted for publication and sent to Elsevier’s production department, and that


reflects any author-agreed changes made in response to peer-review comments. Elsevier will authorize the author manuscript’s public access posting 12 months after final publication. Following the deposit by Elsevier, authors will receive further communications from the NIH with respect to the submission.

Immediate Open Access. If immediate Open Access is desired, a publication fee (see below) is payable by authors or their research funders. These articles will be immediately and permanently free for anyone to read and download. Permitted reuse is defined by the author’s choice of one of the Creative Commons user licenses listed below. Subscription Open Access articles are made available to subscribers as well as developing countries and patient groups through Elsevier’s access programs (http://www.elsevier.com/access). There is no Open Access publication fee for these types of articles.

Open Access fees. JANAC has a publication fee to provide Open Access. It needs to be paid by the authors or their research funders for articles published in Open Access, with the exception noted above. The author’s publication choice will have no effect on the peer review process or acceptance of submitted articles. The Open Access publication fee for JANAC is $USD 2500, excluding taxes. Learn more about Elsevier's pricing policy: www.elsevier.com/openaccesspricing

Open Access user licenses. Authors who have paid a publication fee to make their articles Open Access should choose from one of the following Creative Commons user licenses.

Creative Commons Attribution-Non Commercial-ShareAlike (CC BY-NC-SA). This option is for non-commercial purposes. It lets others distribute and copy the article; create extracts, abstracts, and other revised versions; make adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); text; and data mine from the article, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, do not modify the article in such a way as to damage the author's honor or reputation, and license their new adaptations or creations under identical terms (CC BY NC SA).

Creative Commons Attribution-NonCommercial-NoDerivs (CC-BY-NC-ND). This option is also for non-commercial purposes. It allows others to distribute and copy the article and to include it in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.

Creative Commons Attribution (CC-BY). This option is available only for authors funded by organizations with which we have established an agreement. For a full list of these, please see www.elsevier.com/fundingbodies. Elsevier has established agreements with funding bodies. This ensures that authors can comply with funding body Open Access requirements, including specific user licenses, such as CC-BY. Some authors may also be reimbursed for associated publication fees. www.elsevier.com/fundingbodies

Submission of Manuscripts

JANAC reviews manuscripts with the understanding that they have not been previously published and are not concurrently being considered for publication elsewhere. JANAC uses iThenticate© to detect similarities between submitted papers and previously published materials, including materials written and published by the author(s) of the submitted paper and information on the Internet; we will not review submissions with excessive similarities to other publications.

JANAC invites contributions in the form of featured manuscripts (maximum of 28 submitted pages); research, practice, or program briefs (8-10 submitted pages); case studies (8-10 submitted pages); topical columns, and commentaries (6-8 submitted pages); and media and book reviews (6-8 submitted pages). Letters to the editor are encouraged.

JANAC uses an online manuscript submission and review system. Please visit http://ees.elsevier.com/janac to submit a manuscript electronically. The Web site guides authors through the initial registration process, including the uploading of requisite files. Please note that original source files – not PDF files – are required. A tutorial is available at the site for new authors.


Inquiries regarding manuscript submission or status should be directed to the Managing Editor, Kristen Overstreet, via email at [email protected] or at 1-303-229-8129. All other inquiries should be directed to the Editor, Lucy Bradley-Springer, via e-mail at [email protected] or at 1-303-724-0811. All correspondence, including the Editor's decision and requests for revisions, will be delivered by e-mail to the corresponding author. Manuscript status information is always available for registered authors via the journal's online submission system.

Peer Review

Every submission for a featured manuscript is evaluated by at least two members of the review panel. Reviewers help the editor determine the paper’s relevance and significance, the degree to which it advances knowledge, the quality of scholarly presentation, the integrity of research methods, and clinical content relevant to nursing practice and HIV care.

Manuscript Preparation

Featured Manuscript Submissions

Submissions for featured articles should have the following components (in separate files): (a) title page, including information about each author, corresponding author and her/his email address, disclosure statement, and acknowledgments, if applicable (see the sample title page below for formatting); (b) manuscript body, including abstract and 3-6 key words (on first page), title, manuscript text, references, and tables, if applicable; (c) key considerations (see below for formatting); and (d) figures, if applicable. We accept a combined total of up to 5 tables and figures. Manuscripts should be written and formatted in accordance with the Publication Manual of the American Psychological Association (APA, 2010), 6th ed. guidelines. Please see the JANAC Style Guide (available on our Web site at http://www.nursesinaidscarejournal.org/webfiles/images/journals/jana/styleguide.pdf) for JANAC-specific style issues and exceptions to APA formatting. See below for samples of reference formatting.

Other Submissions

Submissions for research, practice, or program briefs; topical columns and commentaries; guest editorials; and letters to the editor are encouraged. The editor reviews these submissions and determines whether additional input is needed from reviewers. Other submissions should have the following components (in separate files): (a) title page, including information about each author, corresponding author and her/his email address, disclosure statement, acknowledgments (if applicable), and 3-6 key words (see the sample title page below for formatting); (b) manuscript body, including title, text, references, and tables, if applicable; and (c) figures, if applicable. Please limit submission to a total of 2 tables and/or figures per manuscript. These types of submissions do not include an abstract or key considerations.

Components of a Manuscript

Title page. The title page should include each author’s credentials, title/position, affiliation, and location (city and state and/or country), and corresponding author and her/his email address. This information should be listed on the title page as follows (also see sample title page at the end of this document):

Kristen Overstreet, BA

Lucy Bradley-Springer, PhD, RN, ACRN, FAAN

Carol (Pat) Patsdaughter, PhD, RN, ACRN

Kristen Overstreet, BA, is Managing Editor, Origin Editorial, LLC, Austin, Texas, USA. Lucy Bradley-Springer, PhD, RN, ACRN, FAAN, is Associate Professor, School of Medicine, University of Colorado Denver, Aurora, Colorado, USA. Carol (Pat) Patsdaughter, PhD, RN, ACRN, is Professor, College of Nursing and Health Science,


Florida International University, Miami, Florida, USA.

Corresponding Author: Kristen Overstreet: [email protected]

The title page should also include a conflict of interest statement and any desired acknowledgments.

Conflict of Interest Statement. Authors are required to provide full disclosure on actual or potential conflicts of interest relevant to the subject matter of the manuscript that have occurred over the previous 2 years, over the duration of the research being reported on, and/or that can reasonably be expected to occur in the foreseeable future. Disclosures may include, but are not limited to, grants and funding, employment, affiliations, honoraria, consultancies, board positions, royalties, stock options and ownership, or expert testimony. Unless determined to be important to the review process, disclosures will be held confidential until an article is accepted for publication. Disclosure statements will appear with all articles published in the journal. Authors should contact the Managing Editor with questions or concerns, but should err on the side of inclusion when in doubt. Please see the full Conflict of Interest Policy on our Web site at http://www.nursesinaidscarejournal.org/webfiles/images/journals/jana/conflict.pdf

If the author(s) has no conflicts of interest to declare (including relationships with pharmaceutical companies, biomedical device manufacturers, grantors, or other entities whose products or services are related to topics covered in this manuscript), this must be stated. In this case, please use the following statement:

The author(s) report(s) no real or perceived vested interests that relate to this article that could be construed as a conflict of interest.

The following is sample text for disclosure of a real or perceived conflict of interest:

This study was funded in part by ABC Corporation and grant #1-234-5678 from DEF Foundation. Kyle Smith reports having received lecture fees from XYZ Laboratories. Chris Brown disclosed consulting fees from 123 Inc. Madison Jones reports no financial interests or potential conflicts of interest.

Acknowledgments. Please acknowledge all sources of funding in an Acknowledgment Statement on the title page of the manuscript. This is also an appropriate place to acknowledge assistance from non-author colleagues in the development and production of a manuscript.

Manuscript Body

Abstract. Abstracts should contain no more than 150 words, and should appear immediately above the body of the manuscript on page 1. JANAC does not use a structured format for abstracts. Authors will also be asked to provide the abstract as part of the submission process. You may cut and paste your abstract into the submission box. Abstracts are required for all featured articles.

Key words. Key words relating to the content of the manuscript should be listed in alphabetical order and separated by commas. Do not capitalize key terms unless they are proper names. Please provide at least 3 and no more than 6 key words. (For research, practice, or program briefs; topical columns and commentaries; guest editorials; and letters to the editor, please place the key words on the title page.)

Manuscript body. Manuscript pages should be numbered consecutively. The author(s) should use headers as outlined in APA (2010, 6th ed.) to format the manuscript. Do not use more than 3 header levels. A clear and concise writing style is required.

References. The reference section should start on a new page after the end of the body of the paper. The list should represent current literature and appropriate historical references that have been used in the body of the paper as citations or referenced in the tables or figures. References should be limited to about 30 for research manuscripts; review manuscripts may use more references, but with


restraint; brief manuscripts should limit references to 10-15. All citations and references must follow APA (6th ed.) format, including doi numbers. Do not use “et al.” in the reference section. For references with more than seven authors, list the first six authors, then an ellipses (. . . ), then the final author. For references with seven or fewer authors, list all authors’ names. (Please see reference formatting examples at the end of this guide.)

When citing a reference in text, if the citation has six or more authors, use the first author’s last name followed by “et al.,” and the publication date (e.g., Bradley-Springer et al., 2013). If the citation has three to five authors, list all authors the first time and then use the first author’s last name followed by “et al.,” for all subsequent citations. Citations with one or two authors should always list the authors’ names (e.g., Overstreet, 2013; Bradley-Springer & Patsdaughter, 2013).

Key Considerations. All featured manuscripts should include a file that lists 3-6 key points from the article, with a focus on clinical applications. Points should be presented in a bulleted list and focus on main findings and pertinent concepts for nursing care that can be reasonably derived from the manuscript.

Tables. Tables are encouraged if they will help the reader better understand the text. Tables should be self-explanatory and enhance, not duplicate, the text. Tables should be numbered, titled, and referenced in the most appropriate section of the manuscript text. Do NOT place a note in the body saying “place Table XX about here” – tables will be placed as close as possible to the table reference during the type setting process. Any abbreviations in the table should be defined in a “Note.” below the table. Please follow APA (6th ed.) formatting for all tables. Please include tables in numerical order, starting on a new page after the References section in the manuscript body.

Figures

Figures, including photographs, are encouraged if they will help the reader better understand the text. Figures should be self-explanatory and enhance, not duplicate, the text. Figures should be uploaded in a separate file. For best publication quality, figures should be 300 dpi and in jpeg, EPS, or TIFF format. Figures should be numbered, titled, and referenced in the most appropriate section of the manuscript text. Please follow APA (6th ed.) formatting for all figures. See the copyright section below.

Reporting Guidelines

JANAC encourages authors to use the following industry-recognized reporting guidelines to clarify that minimum reporting requirements have been met. For further information on reporting guidelines, visit www.equator-network.org

Study Type Reporting Guideline

Link to Guideline

Randomized Controlled Trial (RTC)

CONSORT Checklist: http://www.consort-statement.org/consort-statement/overview0/

Flowchart - http://www.consort-statement.org/consort-statement/overview0/

Systematic Reviews

Meta-analyses of controlled trials

PRISMA Checklist: http://www.prisma-statement.org/statement.htm

Flowchart - http://www.prisma-statement.org/statement.htm

Quality Improvement (QI)

SQUIRE Statement: http://www.squire-statement.org/

Checklist: http://www.squire-statement.org/assets/pdfs/SQUIRE_guidelines_table.pdf

Ethics (Also see Elsevier’s ethics resources available at http://www.ethics.elsevier.com/index.asp)


Authorship. JANAC follows the ICMJE guidelines for definition of authorship:

Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Authors should meet conditions 1, 2, and 3. (Retrieved from http://www.icmje.org/ethical_1author.html)

If your title page lists more than 6 authors, please explain in your cover letter how each author satisfies the criteria for authorship as stated above. Remember: it may be more appropriate to recognize individuals who have contributed but who do not meet authorship criteria in your acknowledgment statement.

For published manuscripts with more than 6 authors, the author list will appear in APA format on the cover and in the table of contents of the publication issue. These pages will list the first 6 authors and the last author (e.g., Author, A., Author, B., Author, C., Author, D., Author, E., Author, F., . . . Author, Z.). All authors will be listed on the first page of the article in the print journal as well as in the online version.

Author order. After a manuscript has been submitted, any request for a change to the listed order of authors must be accompanied by a statement listing the new order. All of the manuscripts’ authors must sign the request to signify agreement to the change.

Copyright. When using another author’s work, for example, modifying or adapting a published table or figure, or re-publishing a tool or questionnaire, even if you are not copying the material exactly, you may need to seek permission from the original copyright owner. Referencing the original source may not be enough. It is the author’s responsibility to gain needed permissions. Please see this Web site for more information: http://www.copyright.gov/

Dual submission. It is unethical to submit a manuscript to more than one journal at a time for consideration of publication. A manuscript must be rejected or formally withdrawn by the author from one journal before it can be submitted to another journal.

JANAC Style

Please see the “JANAC Style Guide for Authors & Reviewers” document on our Web site at http://www.nursesinaidscarejournal.org/webfiles/images/journals/jana/styleguide.pdf. The Style Guide provides information on JANAC-specific formatting requirements. It is also included in this document.

Accepted Manuscripts

Authors will be asked to sign the appropriate transfer of copyright agreement for their publication type, acknowledging the manuscript transfer. The author is responsible for the content of the original and edited manuscript, accuracy of references, quoted material, and for any violation of copyright.


JANAC Style Guide for Authors and Reviewers

JANAC is edited according to the Publication Manual of the American Psychological Association (APA) style. Please refer to the most recent edition (currently 6th ed.) of the APA Manual frequently. Accept the fact that there is no logic to APA and the rules are precise. Be consistent! JANAC style differs from APA in the following ways:

• When a doi is not available, do not provide the URL of the home page of the journal in place of the doi. Do provide journal name, volume number, issue number, and page number(s).

• In the reference list, we do allow URLs that take the reader directly to a pdf of the referenced materials. Formatting for this type of reference includes the author’s name, year of publication, italicized title of the reference, and then “Retrieved from [specific URL].” This URL should take the reader directly to the article or materials that you are referencing.

• When references are cited in text, provide the reference year in all subsequent citations within a paragraph (this is preferred for clarity).

Formatting

• In the article title and all titles in the reference list, capitalize only the first word, the first word after a colon, and proper nouns.

• Please see the an example of how to format a title page at the end of this document; see directions in the Instructions for Authors (above) for further information.

• For in-text series, use (a), (b), (c), etc. For a series set off in a list, use numbers. • Use italics for:

o Letters used as statistical symbols or algebraic variables o Anchors of a scale [e.g., …from 1 (poor) to 5 (excellent)] o Periodical names and volume numbers in reference lists o A letter, word, or phrase cited as a linguistic example o Titles of books o Genera, species, and varieties o The introduction of a new, technical, key term, or label o Title of a reference retrieved online

• DO NOT use italics for foreign phrases and abbreviations common in English, chemical terms, non-statistical subscripts to statistical symbols or mathematical expressions, or for mere emphasis.

• Abstracts are not structured (no headers or divisions – just one continuous paragraph) and are limited to 150 words. Please include the abstract (when required; see Instructions for Authors) at the beginning of the manuscript body, immediately prior to the introduction.

• Use headers in the body of the paper; see APA manual for proper formatting. You should not use more than 3 levels of headers.

• In the reference list, author names should have a comma between the last name and first and middle initials (Bradley-Springer, L.A.). A comma is used before an ampersand, even if there are only 2 authors (Bradley-Springer, L.A., & Patsdaughter, C.A.).

• The notation et al. is no longer used in the reference list. If a manuscript has seven authors, list all seven with an ampersand (&) between the sixth and seventh authors. If a reference has


eight or more authors, list the first six, then use an ellipses ( . . . ) to represent all authors between the sixth and the final author. After the ellipses, list the final author’s last name and initials. The final author is the final person in the list, not a program name or the name of a group/panel/board.

Word and Abbreviation Choice • HIV/AIDS is not used in JANAC unless it is in a formal title of an organization or a referenced

document. Use AIDS only when speaking of an AIDS diagnosis or when in an organization’s formal title, otherwise use HIV, which is a more inclusive term.

• Do not use “virus” after HIV – it is redundant. • ART is used rather than HAART on the premise that all ART should be highly active. • Use USD for American dollars. • The words “health care” will remain two words. • Hyphenate “risk-taking,” “decision-making,” “HIV-infected” etc., when the compound precedes

the term it modifies (e.g., HIV-infected person, risk-taking behavior). • “HIV-infected” or “infected with HIV” are preferred terms (do not use HIV patient or HIV

positive); “without HIV infection” or “uninfected” are preferred (do not use HIV negative). • Use co-infected and co-infection instead of coinfected and coinfection. • Active voice is preferred over passive voice. Active voice is sometimes best accomplished through

the use of first person pronouns. First person should be used when referring to the authors’ study (i.e., “our study”) or when other wording is confusing (i.e., the current study) or awkward (i.e., the study reported in this paper).

• First person pronouns should also be used when (a) citing direct quotes as a part of qualitative data or in a personal communication, (b) a first-person pronoun will do a better job of making a particular point or emphasis, or (c) the use of a first person pronoun creates clarity.

• Generic names should be used for drugs. • Use “ages” instead of “aged” when describing people (e.g., five men ages 26-68 . . .). • Use Mixed Method (method is not plural and the two words are not hyphenated). • Use “in regard” not “in regards”; use “toward” not “towards”

Punctuation • Use of periods in the following abbreviations: et al. (note that the period comes after al. but not

after et), e.g., i.e. • No periods in degrees, licenses, and certifications (e.g., RN, not R.N.; PhD, not Ph.D.)

Numbers and Statistics • p values – lowercase, italic, no leading zero (e.g., p = .05) • p values – carry out to the numeral (e.g., p = .0001, not p = .000) • Retain commas in numbers with 4 or more digits • Use CD4+ T cell rather than CD cell or CD4 cell • For CD4+ T cell count, use xx cells/mm3; for viral load, use xx copies/mL • Use words to express numbers below 10 (see exceptions in APA Manual – there are many!) • Numbers denoting time are not spelled out (i.e., 1 day, 3 months, 30 minutes, January 5, 1992) • Use “more than,” “less than,” and “at least” in text and use the symbols in parentheses (i.e., > 18

years of age, < .01, > 100).

Tables • Use “Note.” at the bottom of the table to provide additional information. • Footnote symbols: Use superscript lowercase letters in the table (a, b, c, …). The corresponding

footnote is set at baseline followed by a period (a., b., c. …).


• Define all abbreviations used in the table at the bottom of the table. Abbreviations appear in the “Note.” Use “ = ” between the abbreviation and the expansion; separate abbreviations with a semicolon; for example: Note. ART = antiretroviral therapy; CI = confidence interval.

Abbreviations • In general, spell out an abbreviation at first use and place the abbreviation in parentheses. After

that, use the abbreviation consistently throughout the article. If the term is used fewer than three times in the manuscript, spell it out each time and do not provide the abbreviation. Exceptions: HIV, AIDS, and JANAC are used without having to define them.

• Use “vs.” in parentheses, but spell out “versus” in the text.

Journal of the Association of Nurses in AIDS Care Commonly used Abbreviations and Definitions

Abbreviation Definition Abbreviation Definition

3TC lamivudine MRI magnetic resonance imaging ABC abacavir MSM men who have sex with men ACA Affordable Care Act NFV nelfinavir

ADAP AIDS Drug Assistance Programs NGO non-governmental organization AETC AIDS Education Training Center NIAID National Institute of Allergy and

Infectious Disease AIDS acquired immune deficiency

syndrome NIDA National Institute of Drug Abuse

ANAC Association of Nurses in AIDS Care NIH National Institute of Health APV amprenavir NINR National Institute of Nursing

Research ART antiretroviral therapy NNRTI non-nucleoside analogue reverse

transcriptase inhibitor ARV antiretroviral NRTI nucleoside analogue reverse

transcriptase inhibitor ASO AIDS Service Organizations NSEP needle/syringe exchange program ATV atazanavir NtRTI nucleotide analogue reverse

transcriptase inhibitors CAM complementary and alternative

medicine NVP nevirapine

CBO community-based organization nPEP non-occupational post exposure prophylaxis

CDC Centers for Disease Control and Prevention

NSAID non-steroidal anti-inflammatory drug

CI confidence interval OI opportunistic infection CMV cytomegalovirus OSHA Occupational Safety and Health

Administration CNS central nervous system Pap test Papanicolaou test CSF cerebrospinal fluid; colony

stimulating factor PCP Pneumocystis jiroveci pneumonia

d4T stavudine PEP post-exposure prophylaxis ddC zalcitabine PGL persistent generalized

lymphadenopathy DLV delavirdine PI protease inhibitor

DHHS U.S. Department of Health and Human Services

PID pelvic inflammatory disease

EBV Epstein-Barr virus PLWH People living with HIV infection (may be singular or plural; do not use

PLWHs) EFV efavirenz PPD purified protein derivative


Abbreviation Definition Abbreviation Definition EIA or ELISA

enzyme-linked immunosorbent assay QOL quality of life

ENF enfuvirtude RCT randomized controlled trial FDA Food and Drug Administration RPR rapid plasma reagin FPV fosamprenavir RT reverse transcriptase FTC emtricitabine RTV ritonavir

HAV, HBV, HCV

hepatitis A virus, hepatitis B virus, hepatitis C virus

SAMHSA Substance Abuse and Mental Health Services Administration

HCP health care personnel (note: this is plural; do not use HCPs)

SD standard deviation

HIPAA Health Insurance Portability and Accountability Act

SQV saquinavir

HIV human immunodeficiency virus STD, STI sexually transmitted disease, sexually transmitted infection

HPV human papilloma virus TB tuberculosis HSV herpes simplex virus TDF tenofovir IDU injecting drug user/injection drug use TPV tipranzvir IFN interferon UNAIDS Joint United Nations Programme on

HIV/AIDS IgA human immunoglobin A VZIG varicella zoster immune globulin IL interleukin VZV varicella zoster virus

INH isoniazid WB Western Blot KS Kaposi’s sarcoma WHO World Health Organization

MAC Mycobacterium avium complex WSW women who have sex with women MMWR Morbidity and Mortality Weekly

Report ZDV zidovudine


This is the title of the manuscript: Subtitles follow a colon

Kristen Overstreet, BA

Lucy Bradley-Springer, PhD, RN, ACRN, FAAN

Carol (Pat) Patsdaughter, PhD, RN, ACRN

Kristen Overstreet, BA, is Managing Editor, Origin Editorial, LLC, Austin, Texas, USA. Lucy Bradley-Springer, PhD, RN, ACRN, FAAN, is Associate Professor, School of Medicine University of Colorado Denver, Aurora, Colorado, USA. Carol (Pat) Patsdaughter, PhD, RN, ACRN, is Professor, College of Nursing and Health Science, Florida International University, Miami, Florida, USA.

Corresponding Author: Kristen Overstreet: [email protected]

Conflict of Interest Statement

The author(s) report(s) no real or perceived vested interests that relate to this article that could be construed as a conflict of interest.

OR

This study was funded in part by ABC Corporation and grant #1-234-5678 from DEF Foundation. Kyle Smith reports having received lecture fees from XYZ Laboratories. Chris Brown disclosed consulting fees from 123 Inc. Madison Wall reports no financial interests or potential conflicts of interest.

Acknowledgments

Please acknowledge all sources of funding in an Acknowledgment Statement on the title page of the manuscript. This is also an appropriate place to acknowledge assistance from non-author colleagues in the development and production of a manuscript.

Key words: Please provide at least 3 and no more than 6 key words. Key words relating to the content of the manuscript should be listed in alphabetical order and separated by commas; do not capitalize key terms unless they are proper names.

• For research, practice, or program brief; topical columns and commentaries; guest editorials; and letters to the editor, key words should appear on the title page.

• For feature articles, key words should appear below the abstract on page 1 of the manuscript.


References

Blake, A., & Cillizza, C. (2012). Mourdock apologizes for ‘misinterpretation’ of rape comments,

Obama campaign pounces. Retrieved from http://www.washingtonpost.com/blogs/the-

fix/wp/2012/10/24/mourdock-god-intended-for-babies-to-result-from-rape/

Bradley, E.H., Elkins, B.R., Herrin. J., & Elbel, B. (2010). Health and social services expenditures:

Associations with health outcomes. British Medical Journal Quality and Safety. Advance

online publication. doi:10.1136/bmjqs.2010.048363

Bradley-Springer L. (2013). Grace [Video]. Available from

http://www.youtube.com/watch?v=n9UxcwxNmfw

Cook, P.F., Starr, W.M., & Bradley-Springer, L. (2012, November). Building care capacity in rural

states: Results of AETC clinical training activities from 2008-2012. Poster presented at the

Ryan White 2012 Grantee Meeting, Washington, DC.

Kwong, J., & Bradley-Springer, L. (2011). Infection and human immunodeficiency virus infection. In

S.L. Lewis, M.M. Heitkemper, S.R. Dirksen, P.G. O’Brien, & L. Bucher (Eds.). Medical-

surgical nursing: Assessment and management of clinical problems (8th ed., pp. 235-259). St.

Louis, MO: Mosby Elsevier.

Luque, A.E., Jabeen, M., Messing, S., Lane, C.A., Demeter, L., Rose, R., & Reichman, R. (2006).

Prevalence of human papillomavirus genotypes and related abnormalities of cervical

cytological results among HIV-1 infected women in Rochester, New York. Journal of

Infectious Diseases, 192(4), 428-434. doi:10.1086/505876

Myers, J., Bradley-Springer, L., Dufour, M.-S.K., Koester, K., Beane, S., Warren, N., . . . Frank, L.R.

(2012). Supporting the integration of HIV testing into primary care settings. American Journal

of Public Health, 102(6), e25-e32. doi:10.2105/AJPH.2012.300767

Office of National AIDS Policy. (2010, July). National HIV/AIDS strategy for the United States.

Retrieved from http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf

World Health Organization. (2008). Key concepts. Retrieved from

http://www.who.int/social_determinants/thecommission/finalreport/key_concepts/en/

Instructions for Authorscdn.elsevier.com/promis_misc/janacauthorinfostyle... · The Journal of the...

Documents

Transcript of Instructions for Authorscdn.elsevier.com/promis_misc/janacauthorinfostyle... · The Journal of the...